10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001121781-13-000136`
Period End Date	20130331
Filing Date	20130514
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	gthp-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 32 Cash Flow Statement 50

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at March 31, 2013 and December 31, 2012	`AccountsReceivableNet`	$166.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at March 31, 2013 and December 31, 2012	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$44.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Inventory, net of reserves of $44 and $52, at March 31, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Inventory, net of reserves of $44 and $52, at March 31, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$439.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$247.00K	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.96M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	65,492.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.26M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62,282.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62,282.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$361.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	65,492.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.62M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.58M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$61.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$100.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	-	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$419.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$878.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$436.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$65.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Long-term debt payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	-	USD	Point-in-time
Long-term debt payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	$183.00K	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$1.72M	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$2.35M	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 65,492 and 62,282 shares issued and outstanding as of March, 31 2013 and December 31, 2012, respectively	`CommonStockValue`	$62.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 65,492 and 62,282 shares issued and outstanding as of March, 31 2013 and December 31, 2012, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$95.81M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-93.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.86M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.58M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$718.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$167.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	-	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$132.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$158.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-26.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$813.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$714.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$70.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$164.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$930.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.02M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.71M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.88M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-996.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$75.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$15.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$17.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.81M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.01M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	63,671.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	52,471.00	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	$-16.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$112.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$75.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$430.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$198.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$85.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-88.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-65.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-49.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$8.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$113.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-239.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-225.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$25.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-70.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-126.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$84.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$502.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-177.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.19M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.31M	USD	1 Quarter
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-130.00K	USD	1 Quarter
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-101.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-130.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$146.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.65M	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$22.00K	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$169.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$124.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.20M	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$65.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$4.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$5.00K	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.